Close Menu

ICSASG

NEW YORK (GenomeWeb) — An international consortium announced today that it has sequenced the Atlantic salmon genome.

The RFP is "targeting large-scale sequencing centers or a consortium of academic and/or commercial centers that are believed to have the expertise and capacity to participate in a project of this scale."

Canada, Chile, and Norway are seeking a center to finish sequencing the Atlantic salmon genome.

Last year, the consortium, which involves researchers, funding agencies, and industry representatives from Canada, Chile, and Norway, awarded a $6 million contract to Beckman Coulter Genomics for the first phase of the project, which uses Sanger sequencing.

The ICSASG recommends Sanger sequencing or a technology of equivalent read length and quality, rather than one of the current next-generation sequencing technologies, for the first phase of the project. The second phase will likely involve novel sequencing technologies.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.